Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jim Mellon Insider Profile
4 Followers
Jim Mellon, Director at Portage Biotech Inc, holds 8.88M shares in Portage Biotech Inc (Ticker: PRTG), holds 26.84M shares in Condor Gold (Ticker: GB:CNR), holds 3.30M shares in Britannia Life Sciences Inc (Ticker: TSE:BLAB). Most recently, Jim Mellon ― shares of Portage Biotech Inc on ― for an estimated value of ―.
Jim Mellon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jim Mellon holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jim Mellon
Jim Mellon's Trading History
Portage Biotech Inc
―
Director
―
$2.33M
Condor Gold
―
Director, Ten Percent Owner
―
£8.72M
Britannia Life Sciences Inc
―
Former, Ten Percent Owner
―
C$164.90K
List of latest transactions for each holding click on a transaction to see Jim Mellon's performance on stock
You May Also Like
Jim Mellon insider profile FAQ
What is the percentage of profitable transactions made by Jim Mellon?
The percentage of profitable transactions made by Jim Mellon is ―.
What is the average return per transaction made by Jim Mellon?
The average return per transaction made by Jim Mellon is ―.
What stocks does Jim Mellon hold?
Jim Mellon holds: PRTG, GB:CNR, TSE:BLAB stocks.
What was Jim Mellon’s latest transaction?
Jim Mellon latest transaction was an Uninformative Buy of ―.
What was Jim Mellon's most profitable transaction?
Jim Mellon’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jim Mellon's role in Portage Biotech Inc?
Jim Mellon's role in Portage Biotech Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.